Emergence of pristinamycin resistance in India
- PMID: 20177582
- PMCID: PMC2825015
- DOI: 10.4103/0253-7613.48884
Emergence of pristinamycin resistance in India
Abstract
Quinupristin and dalfopristin combination has been advocated as a drug of choice for multi-drug resistant (MDR) gram-positive cocci (GPC). We are reporting two cases of neonatal septicemia, caused by the methicillin resistant Staphylococcus aureus (MRSA), showing primary in vitro pristinamycin resistance. The Minimum inhibitory concentrations (MIC) for pristinamycin in these two cases were 30 mug and 25 mug, respectively. Universal advocacy of pristinamycin for the therapy of MDR GPC infections should be re-evaluated.
Keywords: Dalfopristin/quinupristin; pristinamycin resistance; staphylococcus.
Similar articles
-
Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.Drugs. 1999 Dec;58(6):1061-97. doi: 10.2165/00003495-199958060-00008. Drugs. 1999. PMID: 10651391 Review.
-
Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.Braz J Infect Dis. 2001 Feb;5(1):21-31. doi: 10.1590/s1413-86702001000100004. Braz J Infect Dis. 2001. PMID: 11290311
-
Streptogramins for the treatment of infections caused by Gram-positive pathogens.Expert Rev Anti Infect Ther. 2021 May;19(5):587-599. doi: 10.1080/14787210.2021.1834851. Epub 2020 Oct 26. Expert Rev Anti Infect Ther. 2021. PMID: 33030387 Review.
-
In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.Indian J Med Res. 2004 Dec;120(6):546-52. Indian J Med Res. 2004. PMID: 15654141
-
In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.J Antimicrob Chemother. 1998 Mar;41(3):349-55. doi: 10.1093/jac/41.3.349. J Antimicrob Chemother. 1998. PMID: 9578161
Cited by
-
Bacteriophage types of methicillin-resistant Staphylococcus aureus in a tertiary care hospital.Australas Med J. 2013 Oct 31;6(10):496-503. doi: 10.4066/AMJ.2013.1742. eCollection 2013. Australas Med J. 2013. PMID: 24223065 Free PMC article.
-
Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran.Iran J Microbiol. 2014 Jun;6(3):163-8. Iran J Microbiol. 2014. PMID: 25870749 Free PMC article.
-
Quinpristin-Dalfopristin resistance among methicillin-resistant strains of staphylococci.Indian J Pharmacol. 2010 Feb;42(1):56. doi: 10.4103/0253-7613.62403. Indian J Pharmacol. 2010. PMID: 20606841 Free PMC article. No abstract available.
-
Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review.Pharmacogn Rev. 2015 Jan-Jun;9(17):29-34. doi: 10.4103/0973-7847.156329. Pharmacogn Rev. 2015. PMID: 26009690 Free PMC article. Review.
References
-
- Chamber HF. Antimicrobial agents: Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Burton LL, Lazo JS, Parker KL, editors. Goodman and Gillman.s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. pp. 1173–202.
-
- El Solh N, Allignet J. Staphylococcal resistance to streptogramins and related antibiotics. Drug Resist Updates. 1998;1:169–75. - PubMed
-
- Weisblum B. Resistance to the macrolide –lincosamide –streptogramin antibiotics. In: Fischetti VA, editor. Gram-positive pathogens. Washington, DC: ASM Press; 2000. pp. 694–710.
LinkOut - more resources
Full Text Sources